Johnson & Johnson beat EPS estimates 100% of the time across 18 reported quarters (18 beats, 0 misses). Data sourced from SEC EDGAR.
| Quarter | EPS Estimate | EPS Actual | Surprise | Result |
|---|---|---|---|---|
| Q22026 FY2026 | $2.83 | — | — | Miss |
| Q1 FY2026 | $2.68 | — | — | Miss |
| Q1 FY2026 | $2.68 | $2.70 | +0.8% | Beat |
| 2026-01-21 | $2.46 | $2.46 | +0.0% | Beat |
| Q3 FY2025 | $2.76 | $2.80 | +1.4% | Beat |
| Q2 FY2025 | $2.68 | $2.77 | +3.4% | Beat |
| Q1 FY2025 | $2.58 | $2.77 | +7.4% | Beat |
| 2025-01-22 | $1.99 | $2.04 | +2.5% | Beat |
| Q3 FY2024 | $2.21 | $2.42 | +9.5% | Beat |
| Q2 FY2024 | $2.71 | $2.82 | +4.1% | Beat |
| Q1 FY2024 | $2.64 | $2.71 | +2.6% | Beat |
| 2024-01-23 | $2.27 | $2.29 | +0.9% | Beat |
Back to JNJ overview · JNJ holders · JNJ KPIs
Data sourced from U.S. SEC EDGAR filings. Not personalized investment advice.